John Benson
Director of Finance/CFO at PATHFINDER CELL THERAPY, INC.
Profile
John M.
Benson's current job is as the Chief Financial Officer & Treasurer at Pathfinder Cell Therapy, Inc. He started this position in 2012.
Mr. Benson's former jobs include being the Controller at SyntheMed, Inc. from 2006 to 2011, and the Controller-US Spine Division at Stryker Corp.
from 2003 to 2005.
He also served as the Chief Financial Officer & Treasurer at Pathfinder LLC.
Mr. Benson obtained his undergraduate degree from St. Bonaventure University.
John Benson active positions
Companies | Position | Start |
---|---|---|
PATHFINDER CELL THERAPY, INC. | Director of Finance/CFO | 2011-09-28 |
Former positions of John Benson
Companies | Position | End |
---|---|---|
SyntheMed, Inc.
SyntheMed, Inc. Medical SpecialtiesHealth Technology SyntheMed, Inc. engages in the development and commercialization of medical devices for therapeutic applications. It focuses on the development and commercialization of anti-adhesion, drug delivery products and other surgical implants. The company's products and product candidates, which are based on its proprietary, bioresorbable polymer technology, are primarily surgical implants designed to prevent or reduce the formation of adhesions following a broad range of surgical procedures. Its commercialization efforts have been focused on its lead product, REPEL-CV Bioresorbable Adhesion Barrier, for use in cardiac surgery. The company has changed its name from Life Medical Sciences, Inc. to SyntheMed, Inc. in May 2005. It was founded in August 1990 and is headquartered in Iselin, NJ | Comptroller/Controller/Auditor | 2011-09-15 |
Pathfinder LLC | Director of Finance/CFO | 2011-09-15 |
STRYKER CORPORATION | Corporate Officer/Principal | - |
Training of John Benson
St. Bonaventure University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
STRYKER CORPORATION | Health Technology |
PATHFINDER CELL THERAPY, INC. | Health Technology |
Private companies | 2 |
---|---|
SyntheMed, Inc.
SyntheMed, Inc. Medical SpecialtiesHealth Technology SyntheMed, Inc. engages in the development and commercialization of medical devices for therapeutic applications. It focuses on the development and commercialization of anti-adhesion, drug delivery products and other surgical implants. The company's products and product candidates, which are based on its proprietary, bioresorbable polymer technology, are primarily surgical implants designed to prevent or reduce the formation of adhesions following a broad range of surgical procedures. Its commercialization efforts have been focused on its lead product, REPEL-CV Bioresorbable Adhesion Barrier, for use in cardiac surgery. The company has changed its name from Life Medical Sciences, Inc. to SyntheMed, Inc. in May 2005. It was founded in August 1990 and is headquartered in Iselin, NJ | Health Technology |
Pathfinder LLC | Health Technology |
- Stock Market
- Insiders
- John Benson